Suppr超能文献

基层医疗中孕前咨询的携带者筛查。

Carrier screening in preconception consultation in primary care.

作者信息

Metcalfe Sylvia A

机构信息

Murdoch Childrens Research Institute, Royal Children's Hospital and Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, 3052, Australia,

出版信息

J Community Genet. 2012 Jul;3(3):193-203. doi: 10.1007/s12687-011-0071-z. Epub 2011 Dec 20.

Abstract

Discussing carrier screening during preconception consultation in primary care has a number of advantages in terms of promoting autonomy and enabling the greatest range of reproductive choices. For those with a family history of an inherited condition, this ought to be a routine discussion; however, this can be expanded to include the wider population, especially for those conditions for which carrier frequencies are considered relatively common. There is published literature from around the world regarding experiences with carrier screening in primary care for cystic fibrosis, haemoglobinopathies, fragile X syndrome, Tay-Sachs disease and spinal muscular atrophy, although many of these have tended to focus on consultations during rather than before pregnancy. Overall, these studies reveal that population carrier screening is well received by the participants with apparent minimal psychosocial harms; however, challenges exist in terms of approaches to ensure couples receive adequate information to make personally relevant decisions and for ongoing health professional engagement.

摘要

在初级保健中进行孕前咨询时讨论携带者筛查,在促进自主性和实现最大范围的生育选择方面具有诸多优势。对于有遗传病家族史的人来说,这应该是一次常规讨论;然而,这一讨论范围可以扩大到更广泛的人群,特别是对于那些携带者频率被认为相对较高的疾病。世界各地都有关于初级保健中进行囊性纤维化、血红蛋白病、脆性X综合征、泰-萨克斯病和脊髓性肌萎缩症携带者筛查经验的文献发表,尽管其中许多文献往往侧重于孕期而非孕前的咨询。总体而言,这些研究表明,人群携带者筛查受到参与者的广泛接受,且明显造成最小的心理社会危害;然而,在确保夫妇获得足够信息以做出个人相关决策以及持续的医疗专业人员参与方面仍存在挑战。

相似文献

1
Carrier screening in preconception consultation in primary care.
J Community Genet. 2012 Jul;3(3):193-203. doi: 10.1007/s12687-011-0071-z. Epub 2011 Dec 20.
2
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD010849. doi: 10.1002/14651858.CD010849.pub2.
9
Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?
Aust N Z J Obstet Gynaecol. 2014 Dec;54(6):503-9. doi: 10.1111/ajo.12255. Epub 2014 Oct 28.
10
The aims of expanded universal carrier screening: Autonomy, prevention, and responsible parenthood.
Bioethics. 2019 Jun;33(5):568-576. doi: 10.1111/bioe.12555. Epub 2019 Feb 7.

引用本文的文献

1
Understanding Genetic Screening: Harnessing Health Information to Prevent Disease Risks.
Int J Med Sci. 2025 Jan 21;22(4):903-919. doi: 10.7150/ijms.101219. eCollection 2025.
2
Genetic study on candidates for oocyte donation.
JBRA Assist Reprod. 2025 Mar 12;29(1):61-66. doi: 10.5935/1518-0557.20240087.
5
A Novel Compound Heterozygous Mutation in the DNAH11 Gene Found in Neonatal Twins With Primary Ciliary Dyskinesis.
Front Genet. 2022 Feb 28;13:814511. doi: 10.3389/fgene.2022.814511. eCollection 2022.
7
Awareness and Use of Folic Acid among Women of Childbearing Age.
Ann Glob Health. 2019 Apr 9;85(1):54. doi: 10.5334/aogh.2396.
8
Feasibility of couple-based expanded carrier screening offered by general practitioners.
Eur J Hum Genet. 2019 May;27(5):691-700. doi: 10.1038/s41431-019-0351-3. Epub 2019 Feb 11.
9
Deciding on cystic fibrosis carrier screening: three citizens' juries and an online survey.
Eur J Public Health. 2018 Oct 1;28(5):973-977. doi: 10.1093/eurpub/cky032.
10
Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population.
Eur J Hum Genet. 2018 Feb;26(2):166-175. doi: 10.1038/s41431-017-0056-4. Epub 2018 Jan 10.

本文引用的文献

2
Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population.
BMC Public Health. 2011 Mar 30;11:193. doi: 10.1186/1471-2458-11-193.
3
ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.
Obstet Gynecol. 2011 Apr;117(4):1028-1031. doi: 10.1097/AOG.0b013e31821922c2.
5
Preconceptional genetic carrier testing and the commercial offer directly-to-consumers.
Hum Reprod. 2011 May;26(5):972-7. doi: 10.1093/humrep/der042. Epub 2011 Feb 28.
6
Carrier testing for severe childhood recessive diseases by next-generation sequencing.
Sci Transl Med. 2011 Jan 12;3(65):65ra4. doi: 10.1126/scitranslmed.3001756.
7
Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathology.
J Mol Diagn. 2011 Jan;13(1):3-6. doi: 10.1016/j.jmoldx.2010.11.012. Epub 2010 Dec 23.
10
Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis.
Genet Med. 2011 Feb;13(2):166-72. doi: 10.1097/GIM.0b013e3181fa24c4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验